Status:

RECRUITING

Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)

Lead Sponsor:

University of Nottingham

Collaborating Sponsors:

University of Oxford

Conditions:

Muscle Atrophy

Age-Related Sarcopenia

Eligibility:

MALE

50-90 years

Phase:

NA

Brief Summary

As people age, muscle mass and function is lost and exercise training is an important way to reduce the effects of this and remain independent. However, not everyone can perform this exercise and the ...

Detailed Description

Skeletal muscle is known for its role in locomotion however, muscles are also important for maintaining whole-body metabolic health. Skeletal muscles represent a vast protein store, the amino acids fr...

Eligibility Criteria

Inclusion

  • Participant is willing and able to give informed consent for participation in the study
  • Participant is physically able to complete the resistance exercise training programme

Exclusion

  • • A BMI \<18 or \>35 kg/m2
  • Active cardiovascular, cerebrovascular or respiratory disease: e.g. uncontrolled hypertension (BP \> 160/100), angina, heart failure (class III/IV), arrhythmia, right to left cardiac shunt, recent cardiac event, COPD, pulmonary hypertension or recent stroke
  • Any metabolic disease
  • Clotting dysfunction
  • A history of, or current neurological or musculoskeletal conditions (e.g. epilepsy)
  • Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance (this must remain for ALL UoN FMHS UREC approved studies)
  • Contraindications to MRI scanning including claustrophobia, pacemaker, metal implants etc. which will be assessed through an MRI safety screening questionnaire.
  • Contraindications to the use of Rapamycin e.g. those due scheduled vaccinations (as rapamycin can reduce the efficacy of vaccines).

Key Trial Info

Start Date :

August 6 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT05414292

Start Date

August 6 2021

End Date

May 1 2027

Last Update

April 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Nottingham School of Medicine

Derby, United Kingdom, DE22 3DT